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objectives: The handling of antineoplastic agents results in chronic surface contamination 
that must be minimized and eliminated. This study was designed to assess the potential of 
several chemical solutions to decontaminate two types of work surfaces that were intentionally 
contaminated with antineoplastic drugs.
methods: A range of solutions with variable physicochemical properties such as their 
hydrophilic/hydrophobic balance, oxidizing power, desorption, and solubilization were tested: 
ultrapure water, isopropyl alcohol, acetone, sodium hypochlorite, and surfactants such as 
dishwashing liquid (DWL), sodium dodecyl sulfate (SDS), Tween 40, and Span 80. These solu-
tions were tested on 10 antineoplastic drugs: cytarabine, gemcitabine, methotrexate, etoposide 
phosphate, irinotecan, cyclophosphamide, ifosfamide, doxorubicin, epirubicin, and vincris-
tine. To simulate contaminated surfaces, these molecules (200 ng) were deliberately spread 
onto two types of work surfaces: stainless steel and glass. recovered by wiping with a specific 
aqueous solvent (acetonitrile/hCooh; 20/0.1%) and an absorbent wipe (Whatman 903®), 
the residual contamination was quantified using high-performance liquid chromatography 
(hPLC) coupled to mass spectrometry. To compare all tested cleaning solutions, a perfor-
mance value of effectiveness was determined from contamination residues of the 10 drugs.
results: Sodium hypochlorite showed the highest overall effectiveness with 98% contamina-
tion removed. ultrapure water, isopropyl alcohol/water, and acetone were less effective with 
effectiveness values of 76.8, 80.7, and 40.4%, respectively. ultrapure water was effective on 
most hydrophilic molecules (97.1% for cytarabine), while on the other hand, isopropyl alcohol/
water (70/30, vol/vol) was effective on the least hydrophilic ones (85.2% for doxorubicin and 
87.8% for epirubicin). Acetone had little effect, whatever the type of molecule. Among products 
containing surfactants, DWL was found effective (91.5%), but its formulation was unknown. 
Formulations with single surfactant non-ionics (tween 40 and span 80) or anionic (SDS) were 
also tested. Finally, solutions containing 10–2 m anionic surfactants and 20% isopropyl alco-
hol had the highest global effectiveness at around 90%. more precisely, their efficacy was the 
highest (94.8%) for the most hydrophilic compounds such as cytarabine and around 80.0% 
for anthracyclines. Finally, the addition of isopropyl alcohol to surfactant solutions enhanced 
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their decontamination efficiency on the least hydrophilic molecules. measured values from the 
stainless steel surface were similar to those from the glass one.
Conclusion: This study demonstrates that all decontamination agents reduce antineoplastic 
contamination on work surfaces, but none removes it totally. Although very effective, sodium 
hypochlorite cannot be used routinely on stainless steel surfaces. Solutions containing anionic 
surfactant such as SDS, with a high efficiency/safety ratio, proved most promising in terms of 
surface decontamination.
Keywords: decontamination/methods; detergents; equipment contamination/prevention and control; hazardous 
 substances/analysis; occupational exposure/analysis
inTroDuCTion
Nowadays, antineoplastic drugs are widely used in 
cancer therapies. Given their high toxicity, these sub-
stances represent a potential risk for professionals at 
each step of the healthcare process. The National 
Institute for Occupational Safety and Health has esti-
mated that around 5.5 million healthcare workers are 
potentially exposed to hazardous drugs in the USA. 
Despite publications of guidelines describing han-
dling protocols and the use of biology safety cabinets 
(BSCs) or barrier isolators, surface contamination 
still exists in hospital pharmacy units (Acampora 
et al., 2005; Crauste-Manciet et al., 2005; ISOPP, 
2007). Environmental monitoring has indicated that 
all surfaces could be potentially contaminated (Turci 
et al., 2003; Bussières et al., 2006; Heinemann et al., 
2008; Käslin et al., 2010). Biological monitoring 
has proved that genotoxic effects can be detected 
by the Ames test or SOS chromo tests (urine muta-
genicity, chromosomal aberrations, sister chromatid 
exchanges, and micronuclei) in the urine of nurses 
and pharmacy technicians (Poyen et al., 1988; 
Sessink et al., 1994; Cavallo et al., 2005; Quillardet 
and Hofnung, 2009). Physical effects such as skin 
rashes, adverse reproductive effects (abortions, still-
births, and congenital malformations), leukaemia, 
or cancers can occur (Skov et al., 1990; Connor and 
McDiarmid, 2006). Traces of contamination have 
been described in patients’ rooms and hospital efflu-
ents, among operating theatre personnel, pharmacy 
technicians, and pharmacists (Mahnik et al., 2004, 
2006; Sottani et al., 2010, 2011). Several papers 
have reported antineoplastic drug contamination on 
vials, surfaces, floors, countertops, carts, storage 
bins, waste containers, tabletops, chairs, and linen 
and in the atmosphere of pharmacy units (Mason, 
2003; Connor and McDiarmid, 2006; Touzin et al., 
2008). The main exposure routes have been by der-
mal contact with contaminated surfaces and by inha-
lation of particles (Kromhout et al., 2000; Fransman 
et al., 2005; Connor and McDiarmid, 2006). To 
confront this challenge, the pharmacist strategy 
is first to confine contamination in specific phar-
macy areas within closed working areas (biosafety 
cabinets and isolators) and secondly to reduce the 
risk of contamination on pharmacists and on phar-
macy technicians by using specific devices such as 
containment safety devices rather than needles for 
example. However, there is still a risk of accumula-
tion over time. Efficient decontamination of surfaces 
is therefore of the utmost importance.
Several studies are available on the impact of decon-
tamination procedures to reduce chemical contami-
nation by cytotoxic agents. Raghavan et al. studied 
a water rinsing method on cisplatin decontamina-
tion using liquid chromatography (Raghavan et al., 
2000). Chlorine-based agents reduced the mutagen-
icity of methotrexate (MTX) by inactivating it (Wren 
et al., 1993). Earlier studies described various other 
solutions for cytotoxic agents on different surfaces. 
Multiple compounds [carmustine (BCNU), lomus-
tine (CCNU), chlorozotocin, N-[2-chloroethyl]-N’-
[2,6-dioxo-3-piperidinyl]-N-nitrosourea (PCNU), 
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-
nitrosoure (Methyl-CCNU), mechlorethamine, mel-
phalan, chlorambucil, cyclophosphamide, ifosfamide, 
uracil mustard, and spiromustine] were degraded 
using nickel aluminium in a potassium hydroxyde 
solution without any toxic degradation (Lunn et al., 
1989). Barek et al. proposed two methods for sur-
face decontamination: the first reported almost total 
degradation of melphalan based on its oxidation by 
potassium permanganate in a sodium hydroxide solu-
tion, and the second degraded multiple compounds 
(amsacrine, azathioprine, asparaginase, and thiotepa) 
using sodium hypochlorite and a Fenton reagent [an 
oxidizing solution based on hydrogen peroxide oxi-
dized by catalyst ferrous iron (II)] (Barek et al., 1987, 
1998). Oxidizing agents had already been tested on 
antineoplastic agents (Hansel et al., 1996; Castegnaro 
et al., 1997; Roberts et al., 2006) and assessments 
established on different antineoplastic classes: oxa-
zophosphorine or anthracycline molecules, using 
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hydrogen peroxide and sodium hypochlorite, which 
proved to be effective. Vaporized hydrogen peroxide 
and detergents were also investigated with positive 
results on 5-Fluorouracil, doxorubicin (DOX), and 
cyclophosphamide. Despite all previous studies, to 
date, no clear, effective, and evidence-based cleaning 
recommendations for daily practice exist. The aim 
of this paper is to evaluate the surface decontamina-
tion efficacy of different cleaning solutions through 
a step-by-step controlled study, to provide advice for 
cleaning steps in pharmacy units.
The first part of this experimental work was per-
formed on stainless steel, where aqueous solutions, 
aqueous alcohol solutions, or organic solutions were 
first screened. An improvement was then made on 
selected solutions and finally the optimal volume 
required for decontamination was determined. The 
second part was performed on glass to test the effec-
tiveness of selected solutions. The final objective is to 
provide an effective and clear review of cleaning solu-
tions for the periodic decontamination of work areas.
ExPErimEnTAL
Chemicals and reagents
Antineoplastic agents.  The study was performed 
with the following commercially available cytotoxic 
drugs (Table 1). Reconstitution of etoposide phos-
phate (Etopophos®), gemcitabine (Gemcitabine 
Teva®), and ifosfamide (Holoxan®) was obtained 
with water for injection (Bichsel Laboratories, 
Interlaken, Switzerland). 5% sterile glucose 
(Sintetica, Bioren SA, Couvet, Switzerland) was 
used for the reconstitution of Endoxan®.
Liquid chromatography–mass spectrometry/mass 
spectrometry.   Lichrosolv® HPLC grade acetoni-
trile (ACN) and ultrapure water were purchased 
from Merck (Darmstadt, Germany), and formic 
acid (FA) came from Biosolve (Valkenswaard, the 
Netherlands).
Wiping and desorption material.   Filter paper 
(Protein Saver TM 903 Card) was from Whatman 
(Dassel, Germany), and 1.5 ml polyethylene (PE) 
safe-lock tubes were from Eppendorf AG (Hamburg, 
Germany). Texwipe 3210 cleaning wipers, used as 
received as desorption material, were from ITW 
Texwipe (Kernersville, USA).
Cleaning solutions.   Products used in cleaning solu-
tion formulations are summarized in Table 2. Simple 
solutions were tested as decontamination procedures. 
The choice of these solutions was based on current 
pharmaceutical practice and on scientific publica-
tions. Two kinds of solutions were tested: “elimina-
tion-type” solutions whose main action is to dissolve 
chemical products on the surface and “degradation-
type” solutions that react with the chemical structure 
of compounds, leading to their degradation and the 
formation of expected non-cytotoxic compounds. 
Among “elimination-type” solutions, ultrapure 
Table 1. Commercially available cytotoxic drugs used in the study.
Molecules (acronym) Brand name Hydrophilic (H)/
Hydrophobic (h)
Concentration Manufacturer Town, country
Molecules in test
Irinotecan (IRI) Campto® h 20 mg ml−1 Pfizer AG Zürich, Switzerland
Cytarabine (CYT) Cytosar® H 20 mg ml−1
Gemcitabine (GEM) Gemcitabin Teva® H 20 mg ml−1 Teva Pharma AG Aesch, Switzerland
Vincristine (VI) Vincristine Teva® h 1 mg ml−1
Ifosfamide (IF) Holoxan® H 40 mg ml−1 Baxter AG Volketswil, Switzerland
Cyclophosphamide 
(CP)
Endoxan® H 20 mg ml−1
Methotrexate  
(MTX)
Methotrexate 
Farmos®
H 2.5 mg ml−1 Orion Pharma Zug, Switzerland
Etoposide  
phosphate (ETO)
Etopophos® h 20 mg ml−1 Bristol-Myers  
Squibb SA
Baar, Switzerland
Doxorubicin (DOX) Doxorubine  
Ebewe®
h 2 mg ml−1 Ebewe Pharma Cham, Switzerland
Epirubicin (EPI) Epirubicin Actavis 
Solution®
h 2 mg ml−1 Actavis Regensdorf, Switzerland
Internal standard
IS [13C, 2H3]-MTX H — Alsachim Illkirch, France
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water was tested single as a cleaning solution ref-
erence and as solvent when mixed with surfactants 
such as dishwashing liquid (DWL), span 80, tween 
40, and sodium dodecyl sulphate (SDS). Isopropyl 
alcohol (IPA) 70/30 was also studied because of rec-
ommendations from guidelines for microbiological 
decontamination in chemotherapy production units 
(Le Garlantezec et al., 2011). Hydrophobic solvents 
such as acetone were used to determine its expected 
efficacy on the more hydrophobic compounds. 
Finally, among “degradation-type” solutions, a 
sodium hypochlorite solution, the most currently 
used solution to wash surfaces today, was also tested.
Preparations of compound stock solutions, 
calibration standards, and internal standard
All solutions (i.e. drug reconstitutions and sample 
dilutions) were prepared in appropriate conditions 
(BSC, individual protection) for handling hazardous 
compounds such as cytotoxic agents. The preparation 
of solutions and standards was performed with brand 
drugs to avoid any direct contact of the operator with 
cytotoxic powder and to minimize contamination 
risk during the preparation of solutions. Aliquots 
of the internal standard (IS; 250 µg.ml−1) were pre-
pared with a mixture of ACN and water (75/25, vol/
vol) and stored at −22°C for 12 months with no 
sample degradation observed. Stock solutions of IS 
were diluted daily to 50 ng ml−1 in 20% ACN (vol/
vol) with 0.1% FA  (vol/vol) and were kept stable 
for at least 2 weeks at 2–8°C. A main stock solution 
containing the 10 cytotoxic drugs was prepared by 
diluting at 20 µg.ml−1 concentration each cytotoxic 
compound in water. This solution was further diluted 
to obtain five independent stock solutions at 20, 40, 
200, 1 000, and 4 000 ng ml−1 in 20% ACN (vol/
vol) and 0.1% FA (vol/vol). For calibration standards 
(CS), stock solutions were diluted with the IS solu-
tion at 50 ng ml−1 to obtain five CS at 1, 2, 10, 50, 
and 200 ng ml−1.
Equipment and liquid chromatography–mass 
spectrometry/mass spectrometry conditions
Analyses were carried out with the Accela liq-
uid chromatography system from Thermo Fisher 
Scientific Inc. (Waltham, MA, USA) consisting of 
a quaternary pump equipped with an online degas-
ser, an auto sampler and a solvent platform. The 
chromatographic system was coupled to a Quantum 
Discovery MS from Thermo Fisher Scientific Inc. 
equipped with Ion Max electrospray ionization (ESI) 
interface and a triple quadrupole. The liquid chroma-
tography–mass spectrometry/mass spectrometry sys-
tem was monitored with Xcalibur software (Thermo 
Fisher Scientific). Separations were obtained on 
a ZORBAX SB-C18 RR column with an inner 
diameter of 2.1 mm, a length of 10 cm, and a par-
ticular diameter of 3.5 µm from Agilent Technologies 
(Waldbronn, Germany). The liquid chromatogra-
phy–mass spectrometry/mass spectrometry condi-
tions and method validation have been described in 
detail elsewhere (Nussbaumer et al., 2010).
Table 2. Products used in formulations of cleaning solutions tested.
Products 
(acronym)
International  
name
Manufacturer Commentaries Abbreviation Experimental  
phase
Concentrations  
tested
Acetone Propane-2-one Merck (Darmstadt, 
Germany)
Analysis  
quality
— Screening —
Kleralcohol  
(IPA)
IPA/water Ecolab  
(Farmham, UK)
Guidelines  
reference
IPA Screening 70/30% (vol/vol)
DWL — Migros (Zurich, 
Switzerland)
Contains anionic  
and non-ionic  
surfactants  
(<30%)
DWL Screening,  
Optimization
5%, 10 and 20%  
in ultrapure water  
(vol/vol)
Sodium 
hypochlorite 5%
Sodium 
hypochlorite
Tempia  
(Carouge-Geneve,  
Switzerland)
oxidative agent NaClO Screening,  
Optimization
Diluted at 0.5%  
(vol/vol) in  
ultrapure water
SDS Sodium 
lauryl-sulfate
Merck  
(Hohenbrunn,  
Germany)
CMC: 0.82 ×  
10−3M (Mukerjee  
and Mysels,  
1971)
SDS Optimization 10−4M, 0.5 ×  
10−3M, 10−3M,  
10−2M and 10−1M  
in ultrapure water
Tween 40 Polysorbate 40 Hänseler AG  
(Herisau,  
Switzerland)
non-ionic  
surfactant
— Optimization 10% in ultrapure  
water (vol/vol)
Span 80 Oleatesorbitan 
80 or sorbitan-
(Z)-mono-9-
octadecanoate
non-ionic  
surfactant
— Optimization 10% in ultrapure  
water (vol/vol)
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Decontamination
All tests were performed under a laminar airflow 
hood. The surface to be investigated (10 × 10 cm) was 
contaminated with 50 µl of stock solution sprayed on 
surface (solution containing all 10 cytotoxic agents at 
4000 ng ml−1) using an adjustable volume micropi-
pette. This voluntary contamination was repeated 10 
times for each cleaning solution. For the drying step, 
contaminated surfaces were protected from light in a 
laminar airflow hood for a period of 1 h. After drying, 
different cleaning solutions were applied. These were 
prepared extemporaneously and used directly. 300 µl 
of each cleaning solution was poured onto a 100 cm² 
Texwipe 3210 wipe. A single standard motion from 
top to bottom was adopted to clean each surface.
Wiping and analytical procedure
The wiping step can recover the residual con-
tamination present on the surface after the decon-
tamination step. A validated wiping procedure was 
performed to reclaim remaining cytotoxic com-
pounds (Nussbaumer et al., 2012). To do so, a 1-cm² 
blotting paper (Whatman 903®) was soaked with 
100 µl of an aqueous desorbing solution [ACN: 
water, 20/80 (vol/vol) with 0.1% FA]. The contami-
nated surface was then wiped for 30 s, turning the 
blotting paper regularly. Blotting papers were placed 
in  PE safe-lock tubes, and 1 ml IS solution at 50 ng 
ml−1 was added. Then samples were ultrasonicated 
for 20 min and centrifuged at 4000 rd min−1 for 5 min. 
All samples were immediately placed in the LC auto 
sampler at 15°C and analysed within the day.
Decontamination evaluation
Data extracted from the analytical procedure cor-
respond to residual contamination (RCi,m) of each 
antineoplastic agent. For each molecule, an effi-
ciency index was generated (Effi,m; Equation 1). 
Then, to be able to compare cleaning solutions with 
each other, an overall effectiveness index was calcu-
lated (Effi). It was the average of the 10 efficiency 
indexes (Equation 2). So, this Effi corresponded 
to the overall effectiveness of a solution on the 10 
antineoplastic agents, during a single attempt. To 
validate the overall effectiveness of a solution, each 
cleaning procedure was tested 10 times. As a con-
clusion, in this paper, the median value of those 10 
attempts (EPvalue or Efficiency performance value) 
was used to compare cleaning solutions (Equation 
3). Results were presented as follow: median value 
[minimum value − maximum value].
 Eff RC
i m i m, ,
(%)= −100  (1)
 Eff
Eff
i
i m
i
n
=
∑
,  (2)
 EP median value (Eff )     (  =10)
value
=
i
n n  (3)
Standard deviation (SD) per compound for each 
cleaning solution was also calculated on 10 attempts. 
It indicated the reproducibility of the cleaning solu-
tion on each compound. Due to the numerous man-
ual steps throughout the procedure, its acceptance 
threshold was arbitrarily set at 10%.
Sequence of experiments
In the first part of the study, tests were performed 
on stainless steel. The first “Screening” step involved 
screening solutions with various physicochemical 
characteristics. Working on a solubility procedure, 
tests were carried out with ultrapure water, aqueous-
alcoholic solutions and organic solvents such as 
ACN. An oxidative solution was assessed using an 
aqueous solution of 0.5% sodium hypochlorite. At 
last, complex micellar formulations such as DWL 
diluted in ultrapure water were tested to focus on sur-
factant molecules. In the “Optimization” step, other 
detergent solutions were also tested using single 
anionic and neutral surfactants. SDS was especially 
focused on to consider the impact of its concentra-
tion on decontamination efficacy. Different formula-
tions of aqueous-alcoholic solutions with stable SDS 
concentration were also tested to reduce surfactant 
deposit. Up to this point, tests were performed with 
normalized surfaces and volumes, non-representa-
tive of current decontamination activity. So, in the 
“Practical” step, additional tests were carried out 
over a 0.2 m² surface area with different volumes 
of optimized solution to simulate current cleaning 
methods. Finally, the second part involved tests on 
glass to validate the effectiveness of our solution on 
the most commonly used materials in closed working 
areas. All data are summarized in Table 2.
Statistical analysis
Statistical analysis was performed by analysis of 
variance on ranks following the method of Conover 
and Iman (Conover and Iman, 1981). This method 
was used to compare the effectiveness performance 
value of cleaning solutions. When this analysis 
revealed a significant P value (P < 0.05), contrasts 
were established with the Tukey–Kramer test to 
detect significant differences between couples of 
cleaning solutions with a statistical threshold of 5%. 
Analysis was performed with XLSTAT® software 
(Addinsoft).
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rESuLTS
Screening phase
Considering physicochemical properties of the 
10 antineoplastic agents, two groups of molecules 
can be distinguished: first one corresponding to 
the most hydrophilic substances with cytarabine 
(CYT), gemcitabine (GEM), MTX, etoposide phos-
phate (ETO), cyclophosphamide (CP), and ifos-
famide (IF) and second one to more hydrophobic 
compounds with irinotecan (IRI), DOX, vincristine 
(VI), and epirubicin (EPI). All data and statistical 
analyses performed on the stainless steel surface are 
summarized in Fig. 1 and Table 3.
Ultrapure water, aqueous alcohol, and organic sol-
vents.   Ultrapure water effectiveness was consid-
ered to be insufficient (Fig. 1). It was effective to 
remove CYT, GEM, IF, CP, and VI, but for MTX, 
ETO, IRI, DOX, and EPI, Effi,m values were between 
39 and 73%. Reproducibility was low on hydropho-
bic molecules (e.g. DOX 15.5%), except for VI. For 
IPA/water 70/30 (vol/vol), EPvalue was slightly higher 
than that of ultrapure water (P = 0.041). Effi,m values 
for hydrophilic molecules (CYT, GEM, MTX, ETO, 
IF, and CP) were lower than for ultrapure water and 
inferior to 90.0%. On the other hand, efficacy on the 
most hydrophobic molecules (IRI, DOX, and EPI) 
was superior to that obtained with ultrapure water 
(Fig. 1). Acetone EPvalue was significantly lower than 
ultrapure water and IPA (both with P < 0.0001).
Sodium hypochlorite.   The 0.5% sodium hypochlo-
rite had the highest EPvalues (97.5%) and was signifi-
cantly superior to all other solutions (all P < 0.0001). 
All removal values were superior to 90.0% Table 3. 
For CYT, GEM, MTX, IRI, and VI, Effi,m were even 
superior to 99.0%. For these compounds, SDs were 
inferior to 5%. The lowest Effi,m were found for ETO, 
IF, and CP.
Surfactants.   As shown in Fig. 1, 10% DWL obtained 
a 91.5% EPvalue. Results are reported in Fig. 2.
Optimization phase: focus on surfactants 
molecules
Complex surfactants assessments (DWL).  During 
screening phase, 10% DWL reached a promis-
ing 91.50% EPvalue. Two more concentrations (5 
and 20%) were also tested in order to observe the 
potential of DWL concentration on the antineoplas-
tic removal. No significant difference was observed 
between the three DWL concentrations tested. 20% 
DWL obtained an EPvalue (89.7%) significantly 
Fig. 1. Efficacy per compound and effectiveness performance of each cleaning solution on ten antineoplastic agents during tests 
on stainless steel surface
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higher than ultrapure water (all P < 0.001), but not 
5% DWL (86.1%, P = 0.001). Effi,m values for CYT, 
GEM, IF, CP, and VI were superior to 90.0% and SD 
values close to 10%, whatever the dilutions tested. 
On the other hand, for IRI, DOX, and EPI, the high-
est Effi,m values were obtained using 10% DWL 
(Table 3).
Single surfactant assessments.   Attempts realized 
on non-ionic surfactants (Tween 40 and Span 80): 
Fig. 3 reports results obtained with surfactant solu-
tions. Span 80 effectiveness was not significantly 
different from ultrapure water. It was significantly 
inferior to 10% DWL (P = 0.0001) and to 10−2M 
SDS (P > 0.0002). All of its Effi,m values were 
inferior to the 90.0% threshold, whatever the polarity 
of the molecules. On the other hand, Tween 40 EPvalue 
was significantly superior to Span 80 (P = 0.018) but 
not significantly different from ultrapure water (P 
> 0.0610). Its Effi,m values were superior to 90.0% 
for CYT, GEM, and VI. Its lowest Effi,m values were 
obtained for DOX and EPI. 10−2M-SDS was sig-
nificantly superior to Span 80 (P = 0.0002) but not 
to Tween 40 (P = 0.0610) and to 10% DWL (P = 
0.9276; Fig. 3). Statistically as effective as 10−2M-
SDS, Tween 40 had nevertheless an SD superior to 
10−2M-SDS values for CYT, GEM, MTX, ETO, IF, 
CP, and DOX. As a result, subsequent evaluations 
were made with SDS on a concentration range of 
10−4–10−1M.
Table 3. Efficacy per compound of surfactant solutions on 10 antineoplastic agents and on stainless steel surface.
Modalities CYT GEM MTX ETO IF CP IRI DOX VI EPI EPvalue
Ultrapure 
water
97,10 96,60 71,27 73,35 94,94 94,49 58,10 38,76 95,40 49,13 76.8
2,21 2,28 7,89 9,49 2,30 2,74 7,85 15,50 2,27 19,65 —
Acetone 31,04 34,69 2,90 −16,10 58,98 61,02 58,62 34,82 89,10 51,93 40.4
16,58 15,38 18,07 22,79 12,50 11,18 10,45 21,42 3,64 14,26 —
IPA 81,43 79,40 59,24 64,54 81,08 83,16 85,07 85,21 99,08 87,76 80.7
19,40 21,81 24,30 27,86 13,81 14,71 12,45 15,19 3,23 11,15 —
NaClO 0.5% 99,78 99,34 99,61 93,88 94,35 95,35 99,38 97,63 99,36 98,00 97.5
1,15 2,01 0,78 6,04 13,09 8,45 4,06 2,58 0,05 2,35 —
5% DWL 96,88 96,95 88,00 81,77 94,99 94,91 86,71 80,17 94,52 79,59 86.1
3,18 2,72 3,99 5,84 4,85 4,80 4,81 12,44 2,49 10,40 —
10% DWL 96,50 96,48 82,70 88,45 94,36 94,20 91,66 83,86 96,68 85,97 91.5
3,93 4,23 7,33 7,92 4,38 4,09 10,51 15,21 1,96 14,36 —
20% DWL 95,54 95,46 87,13 77,86 92,42 92,33 86,27 76,94 93,28 73,84 89.7
10,54 8,92 10,33 17,32 10,91 10,37 15,83 19,99 7,22 18,12 —
Span 80 82,36 80,33 66,42 65,82 79,13 80,40 45,47 54,82 79,28 55,06 76.8
16,25 18,67 26,38 42,38 16,19 15,79 28,35 32,19 8,47 29,79 —
Tween 40 92,59 91,48 74,98 66,58 88,67 89,13 84,05 64,68 99,01 63,43 82.7
8,88 9,27 10,96 17,27 9,25 9,38 5,52 19,20 0,57 7,73 —
10−1M-SDS 96,91 97,33 92,10 89,78 95,02 94,98 100,00 93,28 99,72 95,90 95.4
5,32 4,33 6,56 9,27 5,02 4,80 0,00 5,96 0,05 4,14 —
10−2M-SDS 96,57 95,91 84,36 87,38 89,45 89,36 86,92 74,73 96,13 78,03 87.8
4,44 4,13 6,12 6,41 5,06 5,17 6,57 16,93 1,73 7,94 —
0.5 × 
10−2M-SDS
94,90 94,63 81,23 81,55 92,41 91,91 82,79 79,20 92,28 81,60 87.5
4,83 4,78 8,78 12,64 5,18 5,43 8,86 10,68 4,84 9,49 —
10−3M-SDS 94,85 94,13 77,54 73,85 92,16 91,68 75,20 67,92 91,54 70,67 82.6
6,69 7,10 14,84 19,22 7,19 7,55 14,55 13,06 5,93 15,73 —
10−2M-SDS + 
5% IPA
95,83 95,94 90,13 89,66 94,05 93,65 87,77 79,29 96,49 79,42 90.3
7,08 5,70 6,33 6,56 6,23 6,31 5,87 8,20 2,16 10,26 —
10−2M-SDS+ 
20% IPA
95,13 95,47 90,03 92,35 94,32 94,20 89,56 77,77 96,67 80,43 89.6
3,71 3,19 2,76 4,56 4,23 4,55 5,72 10,67 3,41 10,98 —
10−2M-SDS + 
30% IPA
93,24 93,38 89,25 89,18 92,63 92,06 91,60 80,92 98,31 81,59 89.9
6,53 5,67 7,35 7,28 6,42 6,27 5,95 10,43 1,41 11,36 —
Notes: n = 10. 
Results expressed in median values and SD in percentage.
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Attempts realized on anionic surfactant (SDS): 
Results obtained for decontamination solutions con-
taining SDS at different concentrations are shown in 
Fig. 4. The effectiveness of SDS increased propor-
tionally to concentration. Indeed, the lowest EPvalue 
was obtained with 10−3M-SDS. These results were 
significantly lower than 10−1M-SDS (P < 0.0001) 
and 10−2M-SDS (P = 0.026) but not significantly 
different from 0.5 × 10−3M-SDS (P = 0.062). For 
both concentrations around the critical micellar con-
centration (CMC) value (10−2M and 0.5 × 10−2M), 
no significant difference was found [87.8% (83.9 – 
92.3) and 87.5% (83.9 – 92.3); P = 0.997]. For both 
concentrations, all Effi,m values were close to each 
other. For CYT, GEM, and VI, they were superior 
to 90.0% but slightly higher with “10−2M-SDS”. 
However, for DOX and EPI, efficacy was slightly 
lower with 10−2M-SDS. The highest effectiveness 
was obtained with 10−1M-SDS. Despite results sig-
nificantly superior to 10−2M-SDS (P < 0.0001), this 
concentration presented a major drawback. Indeed, a 
thin surfactant film appeared from time to time on the 
surface after the cleaning step. Microbiological con-
tamination could appear inside, making it necessary 
to reduce the risk of formation of the residual film.
Attempts realized with improved anionic surfactant 
(SDS + IPA): To overcome the problem of surfactant 
deposit and to increase solution evaporation, the for-
mulation was tested with the addition of IPA. Despite 
containing as much as 20% IPA, a large deposit of 
surfactant still remained on the stainless steel sur-
face when “10−1M-SDS + 20% IPA” was spread over 
it. Therefore, an SDS concentration of 10−2M was 
selected for further experiments. Results are reported 
in Fig. 5. IPA ranging from 5 to 30% was diluted in an 
aqueous solution and mixed with 10−2M-SDS. For all 
aqueous alcohol mixtures, EPvalues were significantly 
higher than those obtained for an ultrapure water solu-
tion (P < 0.0001 except with “10−2M-SDS + 10%-
IPA”, P = 0.031). However, no significant difference 
was found between 30%-IPA, 20%-IPA, 5%-IPA (and 
10−2M-SDS without IPA; Fig. 5). EPvalues around 90% 
were obtained in all cases. Nevertheless, the mixture 
containing 20%-IPA was the most suitable solution, 
thanks to SD values inferior to our threshold of 10% 
and lower than those of other mixtures (Table 3). As 
already mentioned, IPA improved the decontamina-
tion efficacy of the most hydrophobic compounds, 
while SDS acted on hydrophilic molecules. More 
precisely, Effi,m obtained with “10
−2M-SDS + 20%-
IPA” were superior to SDS alone as far as the most 
hydrophobic molecules were concerned, but they 
were slightly lower for the two most hydrophilic mol-
ecules, CYT and GEM (Table 3).
Fig. 2. Efficacy per compound and effectiveness performance of DWL dilutions on ten antineoplastic agents and on stainless 
steel surface
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Fig. 3. Efficacy per compound and effectiveness performance of surfactant solutions on ten antineoplastic agents and on 
stainless steel surface
Fig. 4. Efficacy per compound and effectiveness performance of SDS range concentration on ten antineoplastic agents and on 
stainless steel surface
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Practical phase: volume sprayed and 
decontamination effectiveness
In this test, the solution was sprayed directly on 
the contaminated surface (0.2 m²), and a new whole 
Texwipe 3210 was used for each trial. Results are 
presented in Table 4. Whatever the volume of mix-
ture used (“10−2M-SDS + 20 %-IPA”), EPvalue was 
superior to 90% and even to 93%. Effectiveness with 
“6 ml” was significantly higher than with “3 ml” 
[97.3% (96.5 – 98.1) versus 96.12% (92.77 – 97.27); 
P = 0.008] or with “1 ml” [97.3% (96.5 – 98.1) ver-
sus 93.9% (78.4 – 94.4); P < 0.0001]. Moreover, SD 
was inferior to the 10% threshold (Table 4).
Decontamination procedure glass versus stainless 
steel surface
Results are presented in Fig. 6, and all data are 
compiled in Table 5. Similar to results found on 
stainless steel, IPA was the least effective on glass. 
With Effi,m values superior to the 90% threshold 
except for IF and CP, sodium hypochlorite was the 
most effective and was significantly different from 
IPA (P < 0.0001) on glass. Nevertheless, it was not 
statistically different from “10−2M-SDS”, unlike 
its use on stainless steel. With an EPvalue of 88.3%, 
“10−2M-SDS” had the same effectiveness on glass as 
on stainless steel. The dispersion of its values was 
less important than those of sodium hypochlorite, 
which may explain the non-statistical difference 
between the two modalities.
DiSCuSSion
As the most widely used solvent in cleaning solu-
tions, ultrapure water had to be evaluated. Its per-
formance highlighted the minimal performance 
required for all other aqueous cleaning solutions. 
According to our results, its effectiveness is not suf-
ficient and optimization was required, especially 
for hydrophobic compounds. IPA/water 70/30 (vol/
vol) was expected to improve decontamination of 
the most hydrophobic compounds. In practice, an 
improvement was found on IRI and anthracyclin 
compounds, but at the same time, deterioration was 
measured on the most hydrophilic ones. Acetone was 
no more suitable at improving the decontamination 
process. Despite a lower polarity than IPA, hydro-
phobic molecules were not more effectively removed 
than with IPA. Furthermore, as far as hydrophilic 
molecules are concerned, acetone was the least effec-
tive solution tested. As a result, evaluating the solu-
bility of single solvents did not seem to be the proper 
solution for decontamination procedure. Two other 
Fig. 5. Efficacy per compound and effectiveness performance of concentration range of optimised solutions, on ten 
antineoplastic agents and on stainless steel surface
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hypotheses were considered: oxidative action and 
modification of solvents’ solubility by adjunction 
of surfactants. For sodium hypochlorite, results are 
in accordance with those obtained by Hansel et al. 
who reported degradation efficacy for CP and an IF 
superior to 98.0% (Hansel et al. 1996). Nevertheless, 
despite its high decontamination potential, the use of 
sodium hypochlorite solutions has major drawbacks. 
First of all, the possibility of cytotoxic agents to be 
degraded in mutagenic residues has already been 
mentioned (Barek et al., 1987, 1998). To avoid this 
phenomenon, a time gap after cleaning (minimum 1 
h) should be respected, but this delay is not feasi-
ble in everyday pharmacy routine (Castegnaro et al., 
1997). It is necessary to clean the surface after use 
with a soaked wipe, otherwise corrosion phenomena 
appear on metals such as stainless steel. Nowadays, 
most barrier isolators and BSCs are made of stainless 
steel and manufacturers do not recommend the use 
of sodium hypochlorite. Finally, according to United 
States Pharmacopeia (USP) (797, Table 2), sodium 
hypochlorite can cause side effects such as skin, eye, 
and respiratory irritations or systemic toxicity. To 
overcome these inconveniences, another decontami-
nation method as surfactant should be considered. 
Already available on the food market, DWL could 
be convenient. The poorer efficacy of 5% DWL can 
be explained by an insufficient concentration of sur-
factants to remove hydrophobic compounds properly 
because of the lack of micelle structures. With 20% 
DWL, a residual film was observed on the stainless 
steel surface, which persisted after the wiping step. 
This was probably the reason for the higher residual 
contamination observed (Table 3). This film can be 
removed with a large volume of water spilled over 
the surface, but this solution is not suitable within 
BSCs. None of these limits were found with the inter-
mediate dilution 10% DWL. Even if its results were 
less effective than those obtained with 0.5% sodium 
hypochlorite, the main advantage of 10% DWL was 
undoubtedly its safety not only for humans but also 
for work surfaces. These results confirmed a previ-
ous work that studied cyclophosphamide chemical 
contamination on a glass vial surface (Touzin et al., 
2008). Nevertheless, as already mentioned, the exact 
composition of DWL was unknown and depending 
on the supplier tested. DWL formulations are usu-
ally based on mixtures of anionic and non-ionic sur-
factants. For a better understanding of DWL action 
and to simplify formulation of cleaning solutions, 
subsequent experiments were focused on a single 
surfactant. Span 80 did not appear to be efficient, 
so attempts were not pursued further. Tween 40 and 
SDS were both effective on stainless steel surface. 
Nevertheless, after a brief literature review, SDS 
appeared to be the most widely employed surfactant 
on decontamination products. An additional benefit 
of SDS is that it is commercially available in cer-
tified laboratory quality powdered form. The use 
of a standardized formulation would allow users to 
guarantee the quality of the cleaning agent. Despite 
its high effectiveness, SDS 10−1M was not selected 
because a residual film was noticed after each decon-
tamination procedure. This residual film was similar 
to the one observed with 20% DWL. CMC is the 
main characteristic to take into account when using 
surfactants. This is found in our results. With a con-
centration 10 times inferior to CMC (SDS 10−3M), 
the effectiveness of the cleaning solution decreased. 
The highest ratio “effectiveness/residual film on 
surface” was found for concentrations around CMC 
(10−2M and 0.5 × 10−2M). To promote the formation 
of micelles, concentration has to be superior to CMC. 
So, SDS 10−2M was selected as the cleaning solution 
for further experiments. To further minimize the risk 
of residual film in everyday use, adjunction of IPA in 
SDS formulation was tested. Deposit of surfactants 
was less serious on a stainless steel surface, and its 
removal by evaporation was found to be especially 
fast with the 20%-IPA concentration. Moreover, 
no decrease of effectiveness (compared with SDS 
10−2M) was noticed using the “10−2M-SDS + 20%-
IPA” mixture. Finally, the “10−2M-SDS + 20%-IPA” 
mixture presented the best balance between decon-
tamination profile and reduced deposit and so was 
selected for further trials.
In our research so far, effectiveness has been 
tested on 100 cm² surfaces with 300 µl of decon-
tamination solution, which is not representative of 
current decontamination in an isolator or a laminar 
airflow hood. Simulations of practical decontamina-
tion on larger surfaces with different volumes were 
Table 4. Efficacy per compound of “10−2M-SDS + 20% IPA” solutions on 0.2 m² stainless steel surface.
Modalities (ml) CYT GEM MTX ETO IF CP IRI DOX VI EPI EPvalue
1 94,68 94,82 94,57 90,52 93,79 93,58 94,47 91,51 96,64 91,76 93.9
3 97,47 97,77 97,35 93,72 97,35 97,19 96,44 93,83 97,11 93,96 96.1
6 97,46 97,65 97,91 95,96 97,69 97,47 99,00 95,22 98,36 95,23 97.3
Notes: n = 2. Results expressed in median values.
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needed to validate both the effectiveness of the solu-
tion and to quantify the volume needed to clean a 
large surface properly. The best results were obtained 
when the largest volume was used. Even when using 
“6 ml”, no deposition of surfactant film was found 
after the wiping procedure. Consequently, a calcu-
lation by proportionality between the standardized 
surface (0.2m²) and a theoretical surface of 1 m² can 
be evaluated. As a result, ratio of cleaning agent to 
surface area between 20 and 30 ml m−² should be 
recommended as an informal rule to clean a stainless 
steel surface properly.
The most frequently encountered materials in 
BSCs and isolators are stainless steel and glass. 
Consequently, further experiments were performed 
on a glass surface with only three selected aqueous 
mixtures. IPA/water 70/30 (vol/vol) is recommended 
by guidelines and has microbiological decontamina-
tion effectiveness. During our study, 0.5% sodium 
hypochlorite, a “degradation-type” solution, pre-
sented the best overall EPvalue, and finally, “10
−2M-
SDS”, developed and tested by ourselves, presented 
the best ratio between performance and safety. IPA 
had the lowest EPvalue (65.3%) and presented no more 
advantage on glass than on stainless steel. NaOCl 
effectiveness (95.8%) was equivalent on both stain-
less steel and glass surfaces. The variations observed 
between the two surfaces can be accounted for by 
their physicochemical characteristics. Glass as a 
more hydrophilic surface has high wettability, and 
stainless steel as metal has higher hydrophobicity 
and lower wettability. Finally, 10−2M-SDS with an 
Fig. 6. Efficacy per compound and effectiveness performance of hypochlorite, IPA and SDS 10-2M on glass surface
Table 5. Efficacy per compound of cleaning solutions on glass surface.
Modalities CYT GEM MTX ETO IF CP IRI DOX VI EPI EPvalue
0.5%  
NaClO
99,74 99,02 99,23 99,53 84,91 86,34 98,22 97,58 99,42 97,35 95.8
8,33 8,41 5,83 6,66 19,08 17,61 7,81 8,60 0,68 6,88 —
10−2M- 
SDS
94,11 94,69 84,58 90,84 92,36 92,21 83,76 80,68 93,46 80,14 88.3
5,74 4,82 10,12 6,51 7,33 7,71 10,49 16,07 5,62 18,58 —
IPA 62,11 65,85 35,70 60,67 64,09 62,08 72,52 78,11 91,15 67,36 65.3
16,44 18,08 23,97 15,91 19,02 27,45 11,38 10,36 0,96 9,47 —
Notes: n = 6. 
Results expressed in median values and SD in percentage.
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88.3 EPvalue was as effective on glass as on stainless 
steel surfaces.
ConCLuSion
The “degradation-type” solution represented by 
sodium hypochlorite was very attractive because 
of oxidation. However, stainless steel as a build-
ing material in isolators and BSC prohibits its 
use. Moreover, this recommendation conveyed by 
manufacturers themselves is reinforced by the risk 
of producing agents with unknown chemical struc-
tures and cytotoxic potential. The “elimination-type” 
solutions demonstrated promising results. The use 
of surfactants such as DWL proves to be efficient 
and reproducible. Previous studies had already 
proved its efficiency on glass surface, but those 
studies were performed with a single antineoplastic 
agent, the cyclophosphamide or the carboplatin (Lê 
et al., 2012). In our study, the DWL efficiency was 
again found on 10 antineoplastic agents. Approved 
on both hydrophilic and hydrophobic agents, DWL 
had nevertheless a major drawback. Indeed, many 
manufacturers are on the household cleaning market 
with their own unknown formulation. Nevertheless, 
DWLs were very convenient and practical prod-
ucts, and further tests will be performed to evaluate 
the relevance of their use in daily practical condi-
tions. During our study, surfactants used alone have 
proved to be effective especially the SDS. Moreover, 
they have the advantage of being available with the 
pharmaceutical certification, which eases their use 
and approval in pharmacy units. SDS allows the 
desorption of antineoplastic agents and reinforces 
their solubility. Their effectiveness was successfully 
proved on both stainless steel and glass surfaces. 
However, the appearance of residual film at high 
concentrations can be a potential source of cross and 
bio contamination. To overcome this problem, IPA 
was added into the formulation. With a quantity of 
20–30 ml m−², the “10−2M-SDS + 20% IPA” formu-
lation was efficient when sprayed on both stainless 
steel and glass surfaces with an efficacy superior to 
97% on a single run. This effectiveness confirms its 
suitable use in current practice. Nevertheless, this 
study was performed on standardized surfaces that 
cannot be substituted for production units used daily 
by healthcare workers, where additional parameters 
have to be taken into account. The best rated decon-
tamination solvents will have to be tested further 
in real environments, as well as on other materials 
(transparent thermoplastic such as poly-methyl-
methacrylate and polycarbonate) and on molecules 
(platine derivatives and 5-fluorouracil) for which no 
data is available. The decontamination procedure 
could also be tested on various supports such as cyto-
toxic packaging which is known to be contaminated 
in its industrial area.
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